Fair Value Measurements and Fair Value of Financial Instruments - Assets and Liabilities on a Recurring Basis (Details) - USD ($) $ in Millions	3 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Dec. 31, 2022
Liabilities [Abstract]
Gain (loss) on sale of investments	$ (44)	$ (139)
Fair Value, Recurring
Assets [Abstract]
Cash equivalents	891		$ 5,804
Investments	21		25
Warrants	11		12
Insurance contracts	169		162
Derivative contracts	51		79
Total Assets	1,143		6,082
Liabilities [Abstract]
Derivative contracts	80		101
Contingent consideration	136		174
Total Liabilities	216		275
Fair Value, Recurring | Quoted Prices in Active Markets (Level I)
Assets [Abstract]
Cash equivalents	891		5,804
Investments	21		25
Warrants	0		0
Insurance contracts	0		0
Derivative contracts	0		0
Total Assets	912		5,829
Liabilities [Abstract]
Derivative contracts	0		0
Contingent consideration	0		0
Total Liabilities	0		0
Fair Value, Recurring | Significant Other Observable Inputs (Level 2)
Assets [Abstract]
Cash equivalents	0		0
Investments	0		0
Warrants	11		12
Insurance contracts	169		162
Derivative contracts	51		79
Total Assets	231		253
Liabilities [Abstract]
Derivative contracts	80		101
Contingent consideration	0		0
Total Liabilities	80		101
Fair Value, Recurring | Significant Unobservable Inputs (Level 3)
Assets [Abstract]
Cash equivalents	0		0
Investments	0		0
Warrants	0		0
Insurance contracts	0		0
Derivative contracts	0		0
Total Assets	0		0
Liabilities [Abstract]
Derivative contracts	0		0
Contingent consideration	136		174
Total Liabilities	$ 136		$ 174